指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症成人机械通气脱机:美国胸科医师学会/美国胸科学会临床实践指南

Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline: Inspiratory Pressure Augmentation During Spontaneous Breathing Trials, Protocols Minimizing Sedation, and Noninvasive Ventilation Immediately After Extubation.
指南 / 共识 · Chest · 2016-11-03
一句话结论CHEST/ATS指南推荐:初始SBT时使用吸气压力增强(弱推荐),使用最小化镇静方案(弱推荐),高风险患者拔管后立即预防性使用无创通气(强推荐)。

美国胸科医师学会(CHEST)与美国胸科学会(ATS)联合发布机械通气脱机指南更新,针对三个PICO问题进行系统评价和GRADE分级。指南对通气超过24小时的患者,条件性(弱)推荐初始自主呼吸试验时使用吸气压力增强,以及使用最小化镇静方案;对高风险患者拔管后立即预防性使用无创通气给出强推荐。推荐受现有证据质量限制。

要点

  • 对机械通气超过24小时的患者,CHEST/ATS条件性(弱)推荐初始SBT时使用吸气压力增强。
  • 对机械通气超过24小时的患者,CHEST/ATS条件性(弱)推荐使用最小化镇静方案。
  • 对高风险患者拔管后立即预防性使用无创通气,CHEST/ATS给出强推荐以改善选定结局。
  • 指南推荐基于GRADE方法评估的证据,推荐强度受现有证据质量限制。

适用人群与场景

  • 机械通气超过24小时的重症成人患者(涉及SBT和最小化镇静的推荐)。
  • 拔管后高风险患者(涉及预防性无创通气的推荐)。

处置流程与药物剂量

  • 对机械通气超过24小时的患者,初始自主呼吸试验时使用吸气压力增强(条件性/弱推荐)。
  • 对机械通气超过24小时的患者,使用最小化镇静的方案(条件性/弱推荐)。
  • 对高风险患者,拔管后立即预防性使用无创通气以改善选定结局(强推荐)。

研究设计与关键结果

  • 指南针对三个PICO问题更新机械通气脱机推荐,采用GRADE方法对证据进行分级。
  • 指南小组权衡获益与负担、证据质量、可行性和可接受性后给出推荐。
  • 两个条件性(弱)推荐分别涉及初始SBT时吸气压力增强和最小化镇静方案。
  • 一个强推荐涉及高风险患者拔管后立即预防性无创通气。

证据类型、等级与局限

  • 证据类型:临床实践指南,基于系统评价和荟萃分析,采用GRADE方法分级。
  • 推荐强度:条件性(弱)推荐两项,强推荐一项。
  • 局限:原文报告推荐受现有证据质量限制。

对床旁实践的改变

  • 对机械通气超过24小时的患者,可考虑在初始SBT时使用吸气压力增强(条件性/弱推荐)。
  • 对机械通气超过24小时的患者,可考虑使用最小化镇静方案(条件性/弱推荐)。
  • 对高风险患者,推荐拔管后立即预防性使用无创通气以改善选定结局(强推荐)。

指南或共识出处

  • 美国胸科医师学会(CHEST)/美国胸科学会(ATS)临床实践指南:重症成人机械通气脱机(Liberation From Mechanical Ventilation in Critically Ill Adults)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: An update of evidence-based guidelines concerning liberation from mechanical ventilation is needed as new evidence has become available. The American College of Chest Physicians (CHEST) and the American Thoracic Society (ATS) have collaborated to provide recommendations to clinicians concerning liberation from the ventilator.

METHODS: Comprehensive evidence syntheses, including meta-analyses, were performed to summarize all available evidence relevant to the guideline panel's questions. The evidence was appraised using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach, and the results were summarized in evidence profiles. The evidence syntheses were discussed and recommendations developed and approved by a multidisciplinary committee of experts in mechanical ventilation.

RESULTS: Recommendations for three population, intervention, comparator, outcome (PICO) questions concerning ventilator liberation are presented in this document. The guideline panel considered the balance of desirable (benefits) and undesirable (burdens, adverse effects, costs) consequences, quality of evidence, feasibility, and acceptability of various interventions with respect to the selected questions. Conditional (weak) recommendations were made to use inspiratory pressure augmentation in the initial spontaneous breathing trial (SBT) and to use protocols to minimize sedation for patients ventilated for more than 24 h. A strong recommendation was made to use preventive noninvasive ventilation (NIV) for high-risk patients ventilated for more than 24 h immediately after extubation to improve selected outcomes. The recommendations were limited by the quality of the available evidence.

CONCLUSIONS: The guideline panel provided recommendations for inspiratory pressure augmentation during an initial SBT, protocols minimizing sedation, and preventative NIV, in relation to ventilator liberation.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Ouellette DR, Patel S, Girard TD, et al. Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline: Inspiratory Pressure Augmentation During Spontaneous Breathing Trials, Protocols Minimizing Sedation, and Noninvasive Ventilation Immediately After Extubation. Chest. 2016. PMID: 27818331. doi:10.1016/j.chest.2016.10.036

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。